AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 351 filers reported holding AVANOS MED INC in Q4 2018. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $357,000 | -14.2% | 10,703 | -11.0% | 0.00% | 0.0% |
| Q4 2021 | $416,000 | +80.1% | 12,024 | +62.3% | 0.00% | 0.0% |
| Q3 2021 | $231,000 | -54.0% | 7,410 | -46.3% | 0.00% | 0.0% |
| Q2 2021 | $502,000 | -30.3% | 13,792 | -16.2% | 0.00% | -50.0% |
| Q1 2021 | $720,000 | +9.8% | 16,450 | +15.1% | 0.00% | 0.0% |
| Q4 2020 | $656,000 | +117.9% | 14,298 | +57.7% | 0.00% | +100.0% |
| Q3 2020 | $301,000 | -1.6% | 9,064 | -12.9% | 0.00% | -50.0% |
| Q2 2020 | $306,000 | -21.9% | 10,403 | -10.5% | 0.00% | 0.0% |
| Q4 2019 | $392,000 | +3.7% | 11,620 | +15.1% | 0.00% | 0.0% |
| Q3 2019 | $378,000 | -12.5% | 10,099 | +2.0% | 0.00% | -33.3% |
| Q2 2019 | $432,000 | -7.3% | 9,899 | -9.4% | 0.00% | 0.0% |
| Q1 2019 | $466,000 | +9.6% | 10,929 | +15.3% | 0.00% | 0.0% |
| Q4 2018 | $425,000 | -45.2% | 9,479 | -16.2% | 0.00% | -40.0% |
| Q3 2018 | $775,000 | – | 11,309 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |